Impax Laboratories, Inc. recalls Lamotrigine Orally Disintegrating Tablets (ODT), 200 mg, 30 Tablets 3 blisters containing 10 tablets each, Rx only, Man…
- Recall date
- August 19, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0215-2017
- FDA classification
- Class I
- Brand / firm
- Impax Laboratories, Inc.
- Sold / distributed
- Distributed Nationwide
Why it was recalled
Labeling; Label Mixup; box labeled to contain 200 mg blister packs but actually contain 100 mg blister packs
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
Lamotrigine Orally Disintegrating Tablets (ODT), 200 mg, 30 Tablets 3 blisters containing 10 tablets each, Rx only, Manufactured by: Watson Pharma Private Ltd., Verna, Salcette Goa INDIA, Distributed by: Impax Generics, Hayward, CA
Get recall alerts
Free email alert whenever Impax Laboratories, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Impax Laboratories, Inc.